NASDAQ Market News 
NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain
WALTHAM, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of ...
DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM
BROSSARD, Quebec, Jan. 22, 2019 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Company”) ...
Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma
Company Announcement First part of regulatory package submitted to the U.S. FDA for label ...
Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing Non-Profit
Notable Labs is donating commercial rights to price, manufacture and distribute pediatric leukemia drug ...
Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans
Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) ...
RadioMedix received $2.0 M SBIR Phase II Contract award from NCI NIH for the targeted alpha-emitter therapy of neuroendocrine cancers.
Houston (TX), Jan. 22, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. is pleased to announce ...
GeoVax to Present at the 2019 ASM Biothreats Conference
Company continues to advance novel vaccines to prevent infectious threats ATLANTA, GA, Jan. 22, ...
Editas Medicine Announces Chief Executive Officer Transition
Katrine Bosley to Step Down as President and CEO Director Cynthia Collins to Serve ...
Global Osseointegration Implants Market to Surpass US$ 10.2 Billion by 2026
Seattle, Jan. 22, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global ...
Innovation Pharmaceuticals Announces Clinical Development Plans for Oral Brilacidin for Inflammatory Bowel Disease
BEVERLY, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...
Apollomics, Inc. Strengthens Leadership with Key Hires
Wilson W. Cheung, CPA appointed Chief Financial OfficerDebra L. Thoma Vallner, PhD, MBA named ...
Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
LEXINGTON, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage ...
Rexahn Presents Updated Preliminary Data on RX-3117 in Pancreatic Cancer at the 2019 ASCO GI Symposium
Overall Response Rate of 38% Observed in the First 24 Patients Who Had At ...